Introduction
Estimates of sample size were determined from previous data 31 to achieve a power of 0.8 at P < 2 6 7 0.05. Data were analysed using GraphPad Prism v6 (GraphPad Software Inc, CA, USA). One-way to compare selected groups to control (Dunnett). For quantitative PCR, data were analysed using a one sample t test compared to PBS (reference value of 1 for the PBS group). Analysis was performed unware of allocation to experimental group however no formal blinding procedure was 2 7 2
used. Data are presented as mean ± SEM unless otherwise stated. * denotes P < 0.05, ** denotes P < 0.01, *** denotes P < 0.001, and **** denotes P < 0.0001. P ≤ 0.05 was considered statistically 2 7 4 significant. concentration-dependent increase in the total number of neutrophils accumulating in brain tissue (incorporating parenchymal and vascular-associated cells) 24 h after LPS injection ( Figure 1C ).
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For further studies, we selected the highest concentration of LPS (5 µg/µl) given the robust and 2 9 2 consistent response. We next assessed the temporal profile of neutrophil recruitment after LPS 2 9 3 injection. As above, LPS induced marked neutrophil accumulation 24 h after injection and similar 2 9 4
numbers were evident at 72 h ( Figure 1D , E). In contrast, by 5 d after injection there were few 2 9 5 neutrophils remaining and a negligible number of cells was also evident at 7 d suggesting the infiltration had almost completely resolved by this time-point. To corroborate and extend this 2 9 7
profile we used flow cytometric quantification of brain cell suspensions. Neutrophils were clearly immunostaining data, there were few neutrophils in vehicle-injected mice and a marked increase in
numbers was detectable at 24 h after injection that peaked at 72 h ( Figure 1G ). Thereafter, remained stable until 28 d after injection. Using the above data we could operatively define phase ( Figure 1H) . We defined the induction/amplification phase as the initial 24 h period after
injection, the plateau phase from 24 -72 h reflecting the largely stable levels of neutrophils, and the 3 0 6 resolution phase from 72 h onwards which is reflective of the decline in neutrophils from peak 3 0 7 levels towards baseline. Thus, intrastriatal injection of LPS induces an acute self-limiting 3 0 8
inflammatory reaction with well-demarcated induction and resolution phases as defined according 3 0 9
to intracerebral neutrophil accumulation and loss. Changes to the adhesive properties and permeability of the vascular endothelium as well as an initial qualitative assessment of selected markers to understand how gross changes to the cerebrovasculature and microglial/macrophage population evolved in relation to the phases of 3 1 7 inflammation defined above. Immunoreactivity of ICAM-1 (Figure 2A) , an adhesion molecule
induced in inflamed endothelium that mediates leukocyte transmigration, was undetectable in
vehicle-injected brain but was induced 24 h after LPS injection. Further induction, reflected by
greater intensity of immunostaining, occurred at 5 d and thereafter there was declining expression.
Permeability of the blood-brain barrier (BBB), a key property of the brain microvascular 3 2 2 endothelium, was assessed by leakage of endogenous IgG, which is normally prevented from injected hemisphere ( Figure 2B) . A focal area of IgG immunoreactivity within the striatum was evident 24 h after LPS injection and this extended to the entire striatum and most cortical areas at general pattern of microglia/macrophage reactivity and in vehicle-injected brains immunoreactivity
was characteristic of ramified microglia evenly distributed throughout the parenchyma ( Figure 2C) .
The intensity of IBA1+ cells within the ipsilateral striatum and cortex increased 24 h after LPS phase and likely reflected reactive changes in resident microglia and the accumulation of monocyte-
derived macrophages. We also noted that there was negligible if any signs of microglial reactivity in vehicle-injected mice suggesting the mechanical nature of the injections themselves was not an
inflammatory trigger and consistent with the absence of histological signs of trauma ( Figure 1D ). In view of the immunohistochemistry observations suggestive of an evolving mixed evident whereas after LPS injection additional CD11b+ populations appeared ( Figure 3A) . These distinguished on the basis of differential CD45 expression intensity. We operationally defined ( Figure 3A) . Although microglial CD45 expression can be induced in the inflamed state, previous
studies have shown that differential CD45 intensity reliably distinguishes these different sources.
Indeed, in the present study at all time-points after LPS injection, mean CD45 intensity on the
hi population was 5-10-fold greater including when microglial CD45 intensity decline thereafter ( Figure 3E ). To corroborate these findings and ensure there was no 3 6 6 misidentification of microglia and Mo/MDMs using differential CD45 expression, we performed a 3 6 7 separate experiment using heterozygous Ccr2 RFP/+ reporter mice that express RFP in monocyte- expression was only found in Ly6G -cells that were also expressing high levels of CD45 and not in LPS is predominantly an expansion of the perivascular macrophage population (which express higher levels of CD45 compared to parenchymal microglia) because previous studies have shown The peak of microglial reactivity corresponds with the inflammation resolution phase 3 8 3
As described above, morphological signs of microglial reactivity were evident during both the relatively modest at 24 h after injection (induction phase) but was maximal at 3-5 d thus coinciding
with the resolution phase and suggesting the magnitude of gross microglial reactivity peaks during F4/80 compared to vehicle-injected mice in microglia, expression remained markedly lower than in
Mo/MDMs (~10-fold lower for CD45; ~2-fold lower for F4/80). In agreement with the above flow
cytometry data, mining of microarray data (see below for details) showed that expression levels of
the genes encoding CD45 and F4/80, Ptprc and Emr1, were significantly elevated in LPS-injected that this will also partly reflect the greater number of CD45 hi cells that accumulate during this phase
as shown in Figure 3) . Overall, these data suggest that the resolution phase is associated with a were differentially expressed across all treatment groups (ANOVA with FDR q < 0.05) and a heat- resolution phase-specific transcripts respectively based on these filtering criteria ( Figure 5C ). This To explore the composition of the transcriptional networks underpinning resolution and their graph and non-subjectively clustered into groups of highly co-expressed genes. Four major clusters 4 2 7
of co-expressed genes dominated the network graph (clusters 1-4) ( Figure 6A ) and we therefore focussed further attention on these. The mean expression profile of each of the major clusters dominant cluster). We manually inspected the contents of each cluster and an overall summary is 4 3 7
presented in Supplementary Table 1 -here we largely focus on the induction-and resolution-
selective clusters summarised in Figure 6C .
The induction-selective cluster (cluster 1) contained 419 nodes/transcripts. Manual inspection of the to interferon-beta ", and "antigen processing and presentation of exogenous peptide antigen via 4 6 0 MHC class I" (Supplementary table 2) . Collectively, these data indicate a potent innate immune class I response among an array of broader inflammatory signalling.
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The resolution-selective cluster (cluster 2) contained 347 nodes/transcripts and comprised groups of of transcriptional networks specific to the resolving phase ( Figure 6C, Supplementary Table 1 ).
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In contrast to the induction clusters, which contained a prominent MHC class I gene set (see given the important role for endo-lysosomal cathepsins in peptide processing and loading for component "lysosome" (Supplementary table 4) . It was also evident that a distinct set of function as central to multiple co-ordinated pro-resolution molecular processes. Recent studies examining the transcriptional basis of microglial identity have described a set of We noticed that the resolution-selective cluster contained a considerable number of these microglial 4 9 7
signature genes, including Fcrls, Hexa, Hexb, Olfml3, Rnase4, Tmem119 , and Trem2 ( Figure 6C ).
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The expression of all these genes was significantly increased 4 d after LPS challenge compared to 1 inflammatory conditions. We did not observe changes in microglial numbers during the transition and with similar kinetic profile as microarray analysis ( Figure 7D) . Overall, these data suggest that In the present study, we sought to develop and validate a model tailored for studying the resolution
of acute brain inflammation and in doing so define its key cellular and molecular characteristics.
2 6
Several interesting observations emerged, notably that the resolution phase appears to be a very future studies to uncover novel CNS resolution mechanisms and modifiers. We used LPS as the inflammatory challenge which has both strengths and weaknesses. As a cell wall component of gram-negative bacteria, LPS is relevant to infectious challenges of the brain. and it is important to consider previous studies that indicated an unrestrained host inflammatory
response to infection may be more problematic than direct pathogen-induced toxicity 58 . LPS is also response to intracerebral LPS injection or experimental stroke in mice. In the present study there
was no evidence that LPS injection caused neuronal toxicity therefore the initial inflammatory (C) quantitative PCR. Expression intensities of (A) selected microglial homeostatic signature genes,
(B) P2Y receptor genes, and (C) amplifying TREM family genes. *P < 0.05, **P < 0.01, ***P < Trem2 after LPS versus PBS injection at indicated timepoints. *P < 0.05, one sample t test
compared to PBS (reference value of 1 for the PBS group). information (2011). (2015). 
